China Merchants Health
Overview
China Merchants Health is a direct investment platform of China Merchants Group, focusing on the healthcare industry, including new technologies like innovative drugs and diagnostics, new payment models like insurance technology, and digitalization within the life sciences sector.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Siwei Biotechnology | Jun 2021 | Series C | Lead |
| Wellgrow Technology | Jan 2022 | Series B Extension | Lead |
| Shanghai Shangyong Technology Co., Ltd. | Aug 2021 | Series C | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is China Merchants Health based?
China Merchants Health is headquartered in Hong Kong, Hong Kong.
When was China Merchants Health founded?
China Merchants Health was founded in 2020.
How many portfolio companies does China Merchants Health have?
China Merchants Health has 3 portfolio companies in Caplight's dataset.
What are some companies in China Merchants Health's portfolio?
Portfolio companies visible on Caplight include Siwei Biotechnology, Wellgrow Technology, Shanghai Shangyong Technology Co., Ltd..
What was China Merchants Health's most recent investment shown here?
China Merchants Health's most recent investment in this portfolio sample was in Wellgrow Technology in 2022.
What sectors does China Merchants Health focus on?
China Merchants Health focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, AI, Data & Cloud Infrastructure.
What company stages does China Merchants Health focus on?
China Merchants Health typically invests at the Mid stage.